News and Blogs

September 22, 2023

Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins

NIH News Release

February 15, 2023

NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19

NIH News Release

February 2, 2023

Lessons learned from the NIH-led research response to COVID-19

NIH News Release

July 20, 2022

Statement from NIH and BARDA on the Novavax COVID-19 Vaccine

NIH News Release

June 2, 2022

Immune modulator drugs improved survival for people hospitalized with COVID-19

NIH News Release

March 1, 2022

Hundreds of COVID trials could provide a deluge of new drugs

Nature Article

January 11, 2022

Statement on NIH Study Testing Convalescent Plasma in Hospitalized Patients

NIH Statement

August 5, 2021

Full-dose blood thinners reduce the need for organ support in moderately ill COVID-19 patients, but not in critically ill patients

NIH News Release

April 19, 2021

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

NIH News Release

April 15, 2021

NIH closes enrollment in trial comparing COVID-19 treatment regimens

NIH News Release

March 31, 2021

NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins

NIH News Release

March 22, 2021

Investigational AstraZeneca vaccine prevents COVID-19

NIH News Release

March 8, 2021

Statement on NIH starting enrollment for third trial of blood clotting treatments for COVID-19

NIH News Release

March 4, 2021

NIH-Sponsored ACTIV-3 Clinical Trial Closes Enrollment into Two Sub-Studies

NIH News Release

March 2, 2021

NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms

NIH News Release

February 27, 2021

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Janssen COVID-19 Vaccine

NIH News Release

February 16, 2021

ACTIV Update: Making Major Strides in COVID-19 Therapeutic Development

NIH Director's Blog

February 11, 2021

Four potential COVID-19 therapeutics enter Phase 2/3 testing in NIH ACTIV-2 trial

NIH News Release

February 8, 2021

Clinical trial in hospitalized COVID-19 patients evaluates long-acting antibody therapy

NIH News Release

January 29, 2021

Janssen Investigational COVID-19 Vaccine: Interim Analysis of Phase 3 Clinical Data Released

NIH News Release

January 5, 2021

Large clinical trial will test combination monoclonal antibody therapy for mild/moderate COVID-19

NIH News Release

December 30, 2020

Peer-reviewed report on Moderna COVID-19 vaccine publishes

NIH News Release

December 28, 2020

Phase 3 trial of Novavax investigational COVID-19 vaccine opens

NIH News Release

December 22, 2020

NIH ACTIV Trial of blood thinners pauses enrollment of critically ill COVID-19 patients

NIH News Release

December 18, 2020

Statement from NIH and BARDA on the FDA Emergency Use Authorization of the Moderna COVID-19 Vaccine

NIH News Release

December 17, 2020

Investigational COVID-19 therapeutics to be evaluated in large clinical trials

NIH News Release

November 16, 2020

Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine

NIH News Release

October 26, 2020

Statement—NIH-Sponsored ACTIV-3 Trial Closes LY-CoV555 Sub-Study

NIH Statement

October 16, 2020

NIH begins large clinical trial to test immune modulators for treatment of COVID-19

NIH News Release

October 13, 2020

NIH study aims to identify promising COVID-19 treatments for larger clinical trials 

NIH News Release

September 23, 2020

Fourth large-scale COVID-19 vaccine trial begins in the United States 

NIH News Release

September 10, 2020

Drs. Collins and Gibbons discuss the launch of adaptive clinical trials of blood-clotting treatments for COVID-19 

NIH Facebook Live

September 10, 2020

NIH launches two trials to test blood thinners in COVID-19 patients

Reuters

September 10, 2020

NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19

NIH News Release

August 31, 2020

Phase 3 Clinical Testing in the US of AstraZeneca COVID-19 Vaccine Candidate Begins

NIH News Release

August 5, 2020

CBS highlights NIH’s launch of ACTIV-2 and ACTIV-3 to develop monoclonal antibody treatment for COVID-19

CBS Evening News

August 4, 2020

Dr. Anthony Fauci and Dr. Collins discuss launch of NIH clinical trials to test antibody treatments in COVID-19 patients

NIH Facebook Live

August 5, 2020

Pharmaceutical companies race to develop monoclonal antibody treatment for COVID-19

CBS Evening News

August 4, 2020

Drs. Francis Collins and Anthony Fauci host a Facebook Live to take questions on the launch of NIH clinical trials to test monoclonal antibody treatments for COVID-19

NIH Facebook Live

August 4, 2020

NIH Director: We Have a Very Tough Several Months Ahead

PBS Amanpour and Company

August 4, 2020

NIH clinical trial to test antibodies and other experimental therapeutics for mild and moderate COVID-19

NIH News Release

August 4, 2020

NIH launches clinical trial to test antibody treatment in hospitalized COVID-19 patients

NIH News Release

July 28, 2020

Combatting COVID-19 with ACTIV: An interview produced by BlackRock, featuring the NIH

FNIH Interview

July 27, 2020

Phase 3 clinical trial of investigational vaccine for COVID-19 begins

NIH News Release

July 25, 2020

At least one COVID vaccine will be ready by end of 2020, says National Institutes of Health director

MSNBC

July 23, 2020

NIH director on speed of vaccine development: “I have never seen anything come together this way”

CBS News

July 23, 2020

NIH to start ‘flurry’ of large studies of potential Covid-19 treatments

STAT

July 22, 2020

Vaccine Watch: NIH director optimistic on vaccine efforts

ABC News

July 8, 2020

NIH launches clinical trials network to test COVID-19 vaccines and other prevention tools

NIH News Release

July 1, 2020

NIH ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development

NIH News Release

May 19, 2020

Coronavirus Q&A: Accelerating Therapies and Vaccines

JAMA

May 18, 2020

Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): An Unprecedented Partnership for Unprecedented Times

JAMA

April 17, 2020

NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options

NIH News Release

This page last reviewed on September 22, 2023